
|Articles|December 1, 2005
Counterfeit drug trade draws congressional scrutiny
Counterfeit prescription drugs pose a "potentially serious health threat" in the United States — one that can result in serious or deadly consequences for patients because of unscrupulous acts of profiteers who take advantage of a lack of uniform regulation and enforcement.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
3
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
4
The Misuse and Overuse of the Word “Robust” in Dermatology
5














